Share Email Print

Proceedings Paper

Interesting method for the synthesis of monofunctionalized phthalocyanines via subphthalocyanines for photodynamic therapy of cancer
Author(s): Rainier G. Senz; Ralf Herter
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

The photodynamic therapy (PDT) of cancer is based on the reaction of dyes, light and oxygen in tumorous tissue. Currently, mainly two different photosensitizers [Photofrin II and Hematoporphyrine derivatives (HPD)] are used in clinical investigations. They are far from being ideal for this purpose as they do not have the required specificity and the absorption maxima do not lie in the ideal region of 760 nm (maximum transmission for human tissue). These properties could potentially be improved by monofunctionalization of the photosensitizers which would allow them to be coupled with tumor specific antibodies. Also, variation of the peripheric substituents would lead to a shift in the absorption maxima to a point nearer to 760 nm. By modification of the methods found in the literature it has been possible to synthesize two new subphthalocyanines and one new subnaphthalocyanine. Starting by reacting 3,6-Dihydroxyphthalicaciddinitrile, 3,6-Dibutyloxyphthalodi-nitrile or 2,3- Dicyanonaphthalene with boron trichloride in a solvent with a high boiling point, it has been possible to form the subphthalocyanines (I) and subnaphthalocyanine (II).

Paper Details

Date Published: 12 January 1995
PDF: 2 pages
Proc. SPIE 2325, Photodynamic Therapy of Cancer II, (12 January 1995); doi: 10.1117/12.199165
Show Author Affiliations
Rainier G. Senz, Technische Fachhochschule Berlin and Laser-Medizin-Zentrum Berlin GmbH (Germany)
Ralf Herter, Technische Fachhochschule Berlin (Germany)

Published in SPIE Proceedings Vol. 2325:
Photodynamic Therapy of Cancer II
Daniel Brault; Giulio Jori; Johan Moan; Benjamin Ehrenberg, Editor(s)

© SPIE. Terms of Use
Back to Top